GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (XLJU:KRKG) » Definitions » Gross-Profit-to-Asset %

Krka d.d. (XLJU:KRKG) Gross-Profit-to-Asset % : 33.58% (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Krka d.d. Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Krka d.d.'s annualized Gross Profit for the quarter that ended in Sep. 2023 was €910 Mil. Krka d.d.'s average Total Assets over the quarter that ended in Sep. 2023 was €2,709 Mil. Therefore, Krka d.d.'s annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 33.58%.


Krka d.d. Gross-Profit-to-Asset % Historical Data

The historical data trend for Krka d.d.'s Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka d.d. Gross-Profit-to-Asset % Chart

Krka d.d. Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.48 40.64 41.23 37.35 37.30

Krka d.d. Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.69 43.36 41.04 38.21 33.58

Competitive Comparison of Krka d.d.'s Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Krka d.d.'s Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka d.d.'s Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka d.d.'s Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Krka d.d.'s Gross-Profit-to-Asset % falls into.



Krka d.d. Gross-Profit-to-Asset % Calculation

Krka d.d.'s annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=974.393/( (2536.988+2687.5)/ 2 )
=974.393/2612.244
=37.30 %

Krka d.d.'s annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=909.936/( (2766.951+2651.991)/ 2 )
=909.936/2709.471
=33.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Krka d.d. Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Krka d.d.'s Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka d.d. (XLJU:KRKG) Business Description

Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.

Krka d.d. (XLJU:KRKG) Headlines

No Headlines